Blood cells with fetal haemoglobin (F-cells) detected by immunohistochemistry as indicators of solid tumours

Journal of Clinical Pathology

Volumn 57, Issue 7, 2004, Pages 740-745

  Wolk, M ^a   Martin, J E ^b   Constantin, R ^c  

^a MINISTRY OF HEALTH   (Israel)

^b ROYAL LONDON HOSPITAL   (United Kingdom)

^c SHAARE ZEDEK MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN F; PROTEIN ANTIBODY; TUMOR MARKER;

ANTIBODY AFFINITY; ARTICLE; BLOOD CELL; CANCER DIAGNOSIS; CONTROLLED STUDY; ERYTHROCYTE; FEMALE; GERM CELL TUMOR; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYDATIDIFORM MOLE; INDICATORS; LYMPHOID TISSUE; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; OVARY ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN PURIFICATION; SEROLOGY; TERATOMA; TISSUE DISTRIBUTION; TROPHOBLAST; TROPHOBLASTIC TUMOR;

FEMALE; FETAL HEMOGLOBIN; HEMATOLOGIC NEOPLASMS; HUMANS; IMMUNE SERA; IMMUNOENZYME TECHNIQUES; MALE; NEOPLASM PROTEINS; NEOPLASMS; NEOPLASMS, GERM CELL AND EMBRYONAL; OVARIAN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 3142523458     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2003.013938     Document Type: Article

References (28)

1. Bunn HF, Forget BG, Ranny HM. Hemoglobin biosynthesis. In: Human hemoglobins. Philadelphia, WB Saunders, 1977:101-34.
2. 2. Clin Chim Acta 1975;50:413-18.
3. Carr BI, Rhabar S, Doroshow JH, et al. Fetal hemoglobin gene activation in phase II study of 5,6-dihydro-5-azacydine for bronchogenic carcinoma. Cancer Res 1987;47:4199-201.
4. Wolk M, Kieselstein M, Brufman G. Evaluation of fetal hemoglobin in various malignancies with reference to the patients' age. Tumour Biol 1988;9:95-100.
5. Bertles JF. Human fetal hemoglobin: significance in diseases. Ann N Y Acad Sci 1974;241:638-52.
6. Jacobson GK, Jacobson M. Immunohistochemical demonstration of hemoglobin F (HbF) in testicular germ cell tumor. Oncodev Biol Med 1983;4:45-51.
7. Wolk M, Newlands ES, Bar-Shira Maymon B, et al. Fetal hemoglobin detected serologically and immunohistochemically in cancer patients. J Tumor Marker Oncol 2000;15:243-52.
8. Lee JC, Hayashi RH, Shepard MK. Fetal hemoglobin in women with normal and with hydatidiform molar pregnancy. Am J Hematol 1982;13:131-9.
9. Underwood JCE, Dangerfield VJM. Immunohistochemical identification of adult and fetal haemopoiesis in the spleen in lymphoma, leukaemia and myeloproliferative disease. J Pathol 1981;134:71-80.
10. Chudwin DS, Rucknagel DL, Aaron P, et al. Fetal hemoglobin and fetoprotein in various malignancies. Acta Haematol 1977;58:288-93.
11. Newman DR, Pierre RV, Linman JW. Studies on the diagnostic significance of hemoglobin F levels. Mayo Clin Proc 1973;48:199-202.
12. Wolk M, Newland AC, De La Salle B, et al. Refinement of plasma fetal hemoglobin (HbF) measurements, as related to whole blood HbF, in cancer patients. Journal of Tumor Marker Oncology 1999;14:115-24.
13. Rochant H, Dreyfus B, Bouguerra M, et al. Refractory anemias, preleukemic conditions and fetal erythropoiesis. Blood 1972;39:721-726.
14. Luna-Fineman S, Shannon KM, Atwater SK, et al. Myelodysplastic and myeloproliferative disorders of childhood: a study of 167 patients. Blood 1999;93:459-66.
15. Albrechtsen R, Wever U, Wimberely PP. Immunohistochemical demonstration of hitherto undescribed localization of hemoglobin A and F in endodermal cells of normal human yolk sac and endodermal sinus tumor. Acta Pathol Microbiol Scand A 1980;88:175-8.
16. Wolk M, Kieselstein M. Graded hemagglutination inhibition for quantitation of human fetal hemoglobin. Clin Chem 1983;29:1372-75.
17. Wolk M, Kieselstein M, Ben-Dor CG, et al. Fetal hemoglobin screening in whole blood and in plasma of cancer patients. Tumor Biol 1991;12:45-51.
18. Hsu SB, Raine L. The use of avidin-biotin-peroxidase complex (ABC) in diagnostic and research pathology. In: DeLellis RA, eds. Advances in immunochemistry. New York: Mason, 1984:31-42.
19. Rodriguez PN, Hafez GR, Messing EM. Nonseminomatous germ cell tumors of the testicle: does extensive staging of the primary tumor predict the likelihood of metastatic disease? J Urol 1986;136:604-8.
20. Thomas GM, Dembo AI, Hacker NF, et al. Current therapy for dysgerminoma of the ovary. Obstet Gynecol 1987;70:268-75.
21. Peterson WF, Prevost EC, Edmunds FT, et al. Benign cystic teratoma of the ovary. Am J Obstet Gynecol 1955;70:368-82.
22. Gabbianelli M, Testa U, Massa A, et al. Hemoglobin switching in unicellular erythroid culture of sibling erythroid burst-forming units: kit ligand induces a dose-dependent fetal hemoglobin reactivation potentiated by sodium butyrate. Blood 2000;95:3555-61.
23. Constantoulakis P, Walmsley M, Patient R, et al. Cell lines produce factors that induce fetal hemoglobin in human BFUe-derived colonies. Blood 1992;80:2650-5.
24. Privitera E, Schiro R, Longoni D, et al. Constitutive expression of GATA-1, EPOR, alpha-globin and gamma-globin genes in myeloid clonogenic cells from juvenile chronic myelocytic leukemia. Blood 1995;86:323-8.
25. Rutherford TR, Clegg JB, Weatherall DJ. K562 human leukaemic cells synthesise embryonic haemoglobin in response to haemin. Nature 1979;280:164-5.
26. Hiromitsu O, Toshiyasu E, Satoshi S, et al. Hemoglobin synthesis of both adult and fetal types in a human CML cell line. J Biochem 1988;104:162-4.
27. Okuno Y, Suzuki A, Ichiba S, et al. Establishment of an erythroid cell line (JK-1) that spontaneously differentiates to red cells. Cancer 1990;66:1544-51.
28. Samid D, Yeh A, Prasanna P. Induction of erythroid differentiation and fetal hemoglobin production in human leukemic cells treated with phenylacetate. Blood 1992;80:1576-81.